Creotech InstrumentsWAR:CRI -2.28%72 PB Ratio is 14.74 as of Jun. 26, 2026, which is 132% above its 10-year median of 6.36. GuruFocus rates WAR:CRI with a GF Score™ of 72/100 and a GF Value™ of zł752.35 (Fairly Valued). The stock has 6 warning signs investors should review. Among 339 Aerospace & Defense companies, Creotech Instruments ranks worse than 92.04% on this metric.
The historical rank and industry rank for Creotech Instruments's PB Ratio or its related term are showing as below:
WAR:CRI'
s PB Ratio Range Over the Past 10 Years
Min: 0.1 Med: 6.36 Max: 21.05
Current: 14.75
During the past 7 years, Creotech Instruments's highest PB Ratio was 21.05. The lowest was 0.10. And the median was 6.36.
WAR:CRI's PB Ratio is ranked worse than 92.04% of 339
companies
in the Aerospace & Defense industry
Industry Median: 3.59
vs WAR:CRI: 14.75
During the past 12 months, Creotech Instruments's average Book Value Per Share Growth Rate was -19.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 31.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 57.20% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Creotech Instruments was 103.80% per year. The lowest was 31.30% per year. And the median was 65.10% per year.
Back to Basics: PB Ratio
Creotech Instruments (WAR:CRI) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Creotech Instruments PB Ratio Related Terms
Creotech Instruments PB Ratio Historical Data
* Premium members only.
The historical data trend for Creotech Instruments's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Aerospace & Defense subindustry, Creotech Instruments's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creotech Instruments PB Ratio vs Aerospace & Defense Industry
For the Aerospace & Defense industry and Industrials sector, Creotech Instruments's PB Ratio distribution charts can be found below:
* The bar in red indicates where Creotech Instruments's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Creotech Instruments (WAR:CRI) has a PB Ratio of 14.74 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Creotech Instruments and its competitors. This is 132% above median its historical median of 6.36. Over the past decade, Creotech Instruments' PB Ratio has ranged from 0.10 to 21.05. According to the industry distribution chart, Creotech Instruments ranks #312 out of 339 companies in the Aerospace & Defense industry, placing it in the top 92%.
Is Creotech Instruments' PB Ratio too high?
Creotech Instruments' current PB Ratio of 14.74 is 132% above median its 10-year median of 6.36. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 21.05. The Aerospace & Defense industry median PB Ratio is 3.59. Creotech Instruments' value of 14.74 is 310.6% above this industry median. Based on the distribution chart, Creotech Instruments ranks #312 out of 339 companies in the Aerospace & Defense industry, which is in the bottom quartile relative to peers. Overall, Creotech Instruments has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Creotech Instruments' PB Ratio compare to GE and RTX?
According to the Aerospace & Defense industry distribution chart, Creotech Instruments ranks #312 out of 339 companies for PB Ratio. This places Creotech Instruments in the lower half of its industry. The industry median PB Ratio is 3.59. Creotech Instruments' value of 14.74 is 310.6% above this benchmark. Historically, Creotech Instruments' own PB Ratio has ranged from 0.10 to 21.05 over the past decade. While the company's 10-year median is 6.36 vs. the industry median of 3.59, Creotech Instruments has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for an Aerospace & Defense company?
The median PB Ratio among Aerospace & Defense companies is 3.59, based on 339 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Creotech Instruments's current PB Ratio of 14.74 is 310.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Creotech Instruments and its competitors. For the Aerospace & Defense industry, the median PB Ratio is 3.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Creotech Instruments's current PB Ratio is 14.74, which is 132% above median its own 10-year median of 6.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creotech Instruments stock overvalued right now?
Based on GuruFocus' analysis, Creotech Instruments (WAR:CRI) is currently considered Fairly Valued. The stock's GF Value™ is zł752.35, compared to a current price of zł727.00 — trading 3.4% below its estimated fair value. The current PB Ratio is 14.74, which is 132% above median its 10-year median of 6.36 and 310.6% above the Aerospace & Defense industry median of 3.59. Creotech Instruments' overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Creotech Instruments (WAR:CRI), the current PB Ratio is 14.74 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Creotech Instruments (WAR:CRI) Overvalued in 2026?
Based on GuruFocus' analysis, Creotech Instruments stock appears to be undervalued.
The current stock price of zł727.00 is trading 3.4% below its estimated GF Value™ of zł752.35.
GuruFocus considers Creotech Instruments to be Fairly Valued.
Key valuation signals for WAR:CRI:
PB Ratio: 14.74 (132% above median its 10-year median of 6.36)
GF Value™: zł752.35 vs. price of zł727.00 (3.4% below fair value)
Industry Position: 310.6% above the Aerospace & Defense median (#312 of 339)
No single metric tells the full story. See the WAR:CRI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Creotech Instruments SA is a provider of advanced space technologies, specialized electronics, and hardware with global applications in areas such as quantum computers, quantum cryptography, quantum physics, and high energy physics laboratories. Its five primary business segments are: NewSpace dedicated to developing a satellite platform and its components; Earth Observation dedicated to developing Earth Observation systems and UAV technology (Unmanned Aerial Vehicle); Science dedicated to developing specialized electronics and components for quantum computers and time synchronization systems; Production dedicated to the manufacture of electronics; ESA Projects dedicated chiefly to projects carried in partnership with or/and commissioned by the European Space Agency (ESA).
72GF Score
Get the complete analysis for WAR:CRI
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:CRI has been successfully added to your 
